In this regard, blocking circulating breast cancer cells with an anti-CD147 antibody could be clinically effective at suppressing the induced CSCs (or MICs), and subsequently preventing the generation of metastatic tumor mass. The gene discussed is BSG; the disease is breast carcinoma.